Login
03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Contraindicated
Reproductive toxicity in animals
Contraindicated
| Froxa : | |
| Type | Medicine Pending |
| Originator | Desferal |
| Agent | Bellapharma |
| Distributor | Bellapharma |
| Laboratory | MS Pharma |
| Manufacturer | MS Pharma |
| Manufacturing Type | G |
| Origin | Jordan |
| ATC | V03AC01 |
Froxa :
Froxa :
Froxa :
Froxa :
Froxa :
| Frequency | Percentage |
|---|---|
| Very Common | ≥ 1/10 |
| Common | ≥ 1/100 - < 1/10 |
| Uncommon | ≥ 1/1,000 - < 1/100 |
| Rare | ≥ 1/10,000 - < 1/1,000 |
| Very Rare | < 1/10,000 |
| Unknown | Cannot be Estimated |
| Effect | Frequency |
|---|---|
| Abdominal pain | Uncommon |
| Acute respiratory distress syndrome | Very rare |
| Anaphylactic reactions | Very rare |
| Anaphylactic shock | Very rare |
| Angioedema (Angioneurotic oedema) (Quincke oedema) | Very rare |
| Arthralgia (Pain joint) (Joint ache) | Very Common |
| Asthma | Uncommon |
| Blood creatinine increased | Not known |
| Blood disorder | Very rare |
| Bone disorder | Common |
| Cataract | Rare |
| Cephalea | Common |
| Convulsion | Not known |
| Corneal opacity | Rare |
| Deafness neurosensory | Uncommon |
| Diarrhoea (Diarrhea) | Very rare |
| Dyschromatopsia | Rare |
| Encephalopathy | Very rare |
| Gastroenteritis yersinia | Very rare |
| Growth retardation | Common |
| Hypotension | Rare |
| Injection site burning | Uncommon |
| Injection site erythema | Very Common |
| Injection site extravasation | Very Common |
| Injection site oedema | Uncommon |
| Injection site pain | Very Common |
| Injection site pruritus | Very Common |
| Injection site reaction | Very Common |
| Injection site scab | Very Common |
| Injection site swelling | Very Common |
| Injection site vesicles | Uncommon |
| Leucopenia (Leukopenia) | Very rare |
| Lightheadedness | Very rare |
| Lung infiltration (pulmonary infiltration) | Very rare |
| Metaphyseal dysplasia | Common |
| Mucormycosis | Rare |
| Muscle spasms | Not known |
| Myalgia | Very Common |
| Nausea | Common |
| Neurological disorders | Very rare |
| Neuropathy peripheral | Very rare |
| Night blindness | Rare |
| Optic neuritis | Rare |
| Paraesthesia (paresthesia) | Very rare |
| Pyrexia | Common |
| Rash generalised | Very rare |
| Renal failure acute (Acute renal insufficiency) (Kidney failure acute) (Renal insufficiency acute) | Very rare |
| Renal tubular disorder | Very rare |
| Retinal degeneration | Rare |
| Shock | Rare |
| Tachycardia | Rare |
| Thrombocytopenia (Thrombopenia) | Very rare |
| Tinnitus | Uncommon |
| Urticaria | Common |
| Vision blurred | Rare |
| Vision loss | Rare |
| Visual acuity reduced | Rare |
| Visual field defect | Rare |
| Vomiting | Uncommon |
Froxa :
Different Units By MoH Code
Froxa MoH 2061671 :
| Form | Powder for solution for injection |
| Packaging | Bottle |
| Package Size | Box of 10 |
| Strength | 500mg |
| Stratum | N/A |
| NSSF | ✘ |
| Quarantine | ✘ |
| Submission date | 24/08/2018 |
| Pending Year | 27/11/2018 |
| Pending Reason | Postponement (mini-committee) |
Price Comparison
| ● Country: | Jordan | |
| ● Package Size: | 10 | |
| ● Public Price: | 43.33 JOD | ( 5,425,825.93 LBP ) |
| ● Pack size unit used: | 10 | |
| ● Cost/Unit: | 4,333 JOD | ( 500,884.00 LBP ) |
| ● Pharmacy Price: | 41.66 JOD | ( 5216706.86 LBP ) |
| ● Reference: | JFDA | |
| ● Pricing Date: | 02/01/2021 | |
| ● Type: | Medicine Authorised |
| ● Country: | KSA | |
| ● Package Size: | 10 | |
| ● Public Price: | 90.15 SAR | ( 2,131,146.00 LBP ) |
| ● Pack size unit used: | 10 | |
| ● Cost/Unit: | 9,015 SAR | ( 212,760.00 LBP ) |
| ● Reference: | sfda | |
| ● Pricing Date: | 16/01/2021 | |
| ● Type: | Medicine Authorised |
- ◼ Lebanon
- ◼ Country of Origin
- ◼ Reference Countries
- ◼ Other Countries
You have to register to view this info
Upload File
Drop File
Uploading, Please wait ....
